Patents by Inventor Ricardo Aguiar

Ricardo Aguiar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lymphoma associated molecules and uses therefor
    Patent number: 7858742
    Abstract: The invention provides isolated nucleic acids molecules, designated BAL nucleic acid molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BAL nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a BAL gene has been introduced or disrupted. The invention still further provides isolated BAL proteins, fusion proteins, antigenic peptides and anti-BAL antibodies. Diagnostic methods using compositions of the invention are also provided.
    Type: Grant
    Filed: August 16, 2004
    Date of Patent: December 28, 2010
    Assignee: Dana-Farber Cancer Institute
    Inventors: Margaret Shipp, Ricardo Aguiar, Yoshi Yakushijin
  • Lymphoma associated molecules and uses therefor
    Patent number: 7632660
    Abstract: The invention provides isolated nucleic acids molecules, designated BBAP nucleic acid molecules, which encode proteins that interact with or bind to BAL molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BBAP nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a BBAP gene has been introduced or disrupted. The invention still further provides isolated BBAP proteins, fusion proteins, antigenic peptides and anti-BBAP antibodies. Diagnostic methods using compositions of the invention are also provided.
    Type: Grant
    Filed: May 9, 2005
    Date of Patent: December 15, 2009
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Margaret A. Shipp, Ricardo Aguiar, Liqun Gu, Kunihiko Takeyama
  • Lymphoma associated molecules and uses therefor
    Publication number: 20070259342
    Abstract: The invention provides isolated nucleic acids molecules, designated BBAP nucleic acid molecules, which encode proteins that interact with or bind to BAL molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BBAP nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a BBAP gene has been introduced or disrupted. The invention still further provides isolated BBAP proteins, fusion proteins, antigenic peptides and anti-BBAP antibodies. Diagnostic methods using compositions of the invention are also provided.
    Type: Application
    Filed: May 9, 2005
    Publication date: November 8, 2007
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Margaret Shipp, Ricardo Aguiar, Liqun Gu, Kunihiko Takeyama
  • Lymphoma associated molecules and uses therefor
    Patent number: 7112420
    Abstract: The invention provides isolated nucleic acids molecules, designated BBAP nucleic acid molecules, which encode proteins that interact with or bind to BAL molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BBAP nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a BBAP gene has been introduced or disrupted. The invention still further provides isolated BBAP proteins, fusion proteins, antigenic peptides and anti-BBAP antibodies. Diagnostic methods using compositions of the invention are also provided.
    Type: Grant
    Filed: September 19, 2001
    Date of Patent: September 26, 2006
    Assignee: Dana-Farber Cancer Institute
    Inventors: Margaret A. Shipp, Ricardo Aguiar, Liqun Gu, Kunihiko Takeyama
  • Nucleic acid sequence encoding lymphoma associated molecule BAL
    Patent number: 6870040
    Abstract: The invention provides isolated nucleic acids molecules, designated BAL nucleic acid molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BAL nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a BAL gene has been introduced or disrupted. The invention still further provides isolated BAL proteins, fusion proteins, antigenic peptides and anti-BAL antibodies. Diagnostic methods using compositions of the invention are also provided.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: March 22, 2005
    Assignee: Dana-Farber Cancer Institute
    Inventors: Margaret Shipp, Ricardo Aguiar, Yoshi Yakushijin
  • Lymphoma associated molecules and uses therefor
    Publication number: 20050014186
    Abstract: The invention provides isolated nucleic acids molecules, designated BAL nucleic acid molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BAL nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a BAL gene has been introduced or disrupted. The invention still further provides isolated BAL proteins, fusion proteins, antigenic peptides and anti-BAL antibodies. Diagnostic methods using compositions of the invention are also provided.
    Type: Application
    Filed: August 16, 2004
    Publication date: January 20, 2005
    Applicant: Dana-Farber Cancer Institute
    Inventors: Margaret Shipp, Ricardo Aguiar, Yoshi Yakushijin
  • Lymphoma associated molecules and uses therefor
    Publication number: 20020120112
    Abstract: The invention provides isolated nucleic acids molecules, designated BBAP nucleic acid molecules, which encode proteins that interact with or bind to BAL molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BBAP nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a BBAP gene has been introduced or disrupted. The invention still further provides isolated BBAP proteins, fusion proteins, antigenic peptides and anti-BBAP antibodies. Diagnostic methods using compositions of the invention are also provided.
    Type: Application
    Filed: September 19, 2001
    Publication date: August 29, 2002
    Applicant: Dana-Farber Cancer Institute
    Inventors: Margaret A. Shipp, Ricardo Aguiar, Liqun Gu, Kunihiko Takeyama